GlassScriptPhysician profile
Adam Shapiro
NPI 1639396377
$1,865.62
in general payments reported to CMS, 2019-2025
18 companies · $886 in 2025
The $886 reported for 2025 was more than what 97% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2020: $104 · 2021: $75.18 · 2022: $305 · 2023: $48.98 · 2024: $341 · 2025: $886.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,116 · Travel and Lodging: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,115.82 |
| Travel and Lodging | $160.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Treace Medical Concepts, INC. | $588.09 | 2022-2025 | |
| Abbott Laboratories | $309.06 | 2022-2025 | Proclaim |
| Smith+Nephew, INC. | $301.99 | 2019-2025 | Bone Anchors With Arthroscopic Delivery System, Grafix Pl |
| Stryker Corporation | $135.98 | 2025 | Prostep, 7 X 23mm Citrelock Implant, Smart Toe |
| Sanara Medtech INC. | $131.52 | 2025 | Celleraterx |
| Vertex Pharmaceuticals Incorporated | $107.05 | 2019-2020 | |
| Organogenesis INC. | $40.11 | 2021 | |
| Medtronic, INC. | $39.54 | 2023-2024 | Venaseal, Intellis Adaptivestim |
| Sebela Pharmaceuticals INC. | $32.55 | 2021-2023 | Naftin |
| Atland Pharmaceuticals, LLC | $32.53 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Polarityte, INC. | $29.39 | 2019 | |
| Kerecis Limited | $21.68 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Averitas Pharma INC. | $19.94 | 2025 | Qutenza |
| Hartmann USA, INC. | $19.09 | 2021 | |
| Convatec INC. | $16.74 | 2023 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $13.93 | 2025 | |
| Medline Industries LP | $13.71 | 2019 | |
| Bioventus LLC | $12.72 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Shapiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.